Results 131 to 140 of about 7,838 (234)
Linong Ji,1 Kyung Wan Min,2 Juliana Oliveira,3 Thomas Lew,4 Ran Duan3 1Department of Endocrinology, Peking University People's Hospital, Beijing, People's Republic of China; 2Department of Endocrinology, Eulji Hospital, Seoul, Republic of Korea ...
Ji L, Min KW, Oliveira J, Lew T, Duan R
doaj
Insulin Treatment for Gestational Diabetes Mellitus
Introduction: Gestational diabetes is one of the most common pathologies in pregnancy that can potentially cause other complications, both to the mother and the fetus.
I Gde Sastra Winata +4 more
doaj +1 more source
Background: Persistent glucose variability is a frequent condition in type 1 diabetes. Continuous subcutaneous insulin infusion (CSII) is a rational option to overcome this clinical issue; however, no comparative studies have been reported for aspart and
Scaramuzza A. +10 more
core +1 more source
Immediate and Late Onset Forms of Insulin Hypersensitivity Presenting with Glucose Dysregulation
We report the case of a 35-year-old woman allergic to detemir, neutral protamine Hagedorn, and glargine. Initially, local reactions to the insulin preparations occurred, which continued even after the types of insulin and the application areas were ...
Ceyda TUNAKAN DALGIÇ +4 more
doaj
Insulin Lispro: A Pharmacoeconomic Review of its Use in Diabetes Mellitus
Insulin lispro is a recombinant insulin analogue with transposed amino acids (proline and lysine) at positions 28 and 29 near the C-terminus of the B-chain.
Greg L. Plosker, Christopher J. Dunn
core
Lispro Insulin and Metformin Versus Other Combination in the Diabetes Mellitus Type 2 Management after Secondary Oral Antidiabetic Drug Failure [PDF]
The purpose of the study was to find out differences between treatments of diabetes type 2 after secondary oral antidiabetic drug failure. Three different methods of treatment were compared: lispro insulin in combination with metformin, glimepiride ...
Damir Buković +15 more
core +1 more source
Heather Ulrich1,4, Benjamin Snyder1,Satish K Garg1,2,31Barbara Davis Center for Childhood Diabetes; 2Department of Medicine; 3Pediatrics; 4Department of Clinical Pharmacy, School of Pharmacy, University of Colorado at Denver and Health Sciences Center ...
Heather Ulrich +2 more
doaj
Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of ...
A. S. Kolbin +5 more
doaj
Switching From Regular U-500 to Insulin Lispro U-200 in an Automated Insulin Delivery System. [PDF]
Meade LT, Theroux J.
europepmc +1 more source
Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation. [PDF]
Lu J, Chen K.
europepmc +1 more source

